These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21394705)

  • 21. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
    Visser PJ; Scheltens P; Verhey FR
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1348-54. PubMed ID: 16170074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective attention deficits associated with mild cognitive impairment and early stage Alzheimer's disease in adults with Down syndrome.
    Krinsky-McHale SJ; Devenny DA; Kittler P; Silverman W
    Am J Ment Retard; 2008 Sep; 113(5):369-86. PubMed ID: 18702557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semantic memory and language dysfunction in early Alzheimer's disease: a review.
    Verma M; Howard RJ
    Int J Geriatr Psychiatry; 2012 Dec; 27(12):1209-17. PubMed ID: 22298328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
    Matsuda O
    Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: current knowledge, management and research.
    Gauthier S; Panisset M; Nalbantoglu J; Poirier J
    CMAJ; 1997 Oct; 157(8):1047-52. PubMed ID: 9347775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention is key to successful management of Alzheimer disease.
    DeKosky S
    Alzheimer Dis Assoc Disord; 2003; 17 Suppl 4():S99-104. PubMed ID: 14512815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive topographical disorientation: a case of focal Alzheimer's disease.
    Grossi D; Fasanaro AM; Cecere R; Salzano S; Trojano L
    Neurol Sci; 2007 Apr; 28(2):107-10. PubMed ID: 17464476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of Alzheimer's disease.
    Grossberg GT
    J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.
    Bottino CM; Carvalho IA; Alvarez AM; Avila R; Zukauskas PR; Bustamante SE; Andrade FC; Hototian SR; Saffi F; Câmargo CH
    Clin Rehabil; 2005 Dec; 19(8):861-9. PubMed ID: 16323385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global approach to multichannel electroencephalogram analysis for diagnosis and clinical evaluation in mild Alzheimer's disease.
    Yoshimura M; Isotani T; Yagyu T; Irisawa S; Yoshida T; Sugiyama M; Minami T; Sugimoto T; Nobuhara K; Okugawa G; Kinoshita T
    Neuropsychobiology; 2004; 49(3):163-6. PubMed ID: 15034231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognitive disorders].
    Asada T
    Seishin Shinkeigaku Zasshi; 2006; 108(7):772-6. PubMed ID: 17131547
    [No Abstract]   [Full Text] [Related]  

  • 38. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profiles of late-onset semantic dementia, compared with early-onset semantic dementia and late-onset Alzheimer's disease.
    Shimizu H; Komori K; Fukuhara R; Shinagawa S; Toyota Y; Kashibayashi T; Sonobe N; Matsumoto T; Mori T; Ishikawa T; Hokoishi K; Tanimukai S; Ueno S; Ikeda M
    Psychogeriatrics; 2011 Mar; 11(1):46-53. PubMed ID: 21447109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.